Holly A. Wandell, PA-C

Holly Wandell practices at WeCare at The Green Home in Wellsboro, Pennsylvania.

Holly Wandell's NPI, 1902052699, was assigned on August 13, 2008. Holly Wandell holds Pennsylvania license MA053461.

Holly Wandell's primary practice is WeCare at the Green Home, at 37 Central Avenue, Wellsboro, PA 16901 in Tioga County. The practice phone is (570) 724-3131.

Holly Wandell's primary practice is WeCare at The Green Home in Wellsboro, Pennsylvania. The medical group on file is Vital Healthcare Solutions. Dmand AI also links Holly Wandell to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Holly Wandell practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Holly Wandell's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Holly Wandell is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Holly Wandell is licensed in Pennsylvania.

Dmand AI lists alzheimer's disease, anxiety, bipolar disorder, depression, drug use disorders, fibromyalgia and chronic pain, insomnia and intellectual and developmental disabilities among the conditions Holly Wandell treats.

CMS data shows 2,854 Medicare services from Holly Wandell across 6 procedure codes in 2024, for 322 Medicare patients. Medicare paid $200,271 for them.

CMS counts 322 Medicare patients who saw Holly Wandell in 2024. The largest group is 85 and over, with 116 patients. 75% of them have depression, and 75% have high blood pressure. 62% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Holly Wandell's median patient age at 80, with 62% women.

In 2024, Holly Wandell wrote 103 Medicare Part D claims for 11 patients. 77% of them were for generic drugs. CMS names the drug for 39 of them, across 3 drugs with 11 or more claims each, at $10,741 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Holly Wandell for performance year 2024, reported through an alternative payment model (APM).

CMS Open Payments shows 1 general payment to Holly Wandell from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Indivior Inc. paid the most, $25.